Quadrant Capital Group LLC Adma Biologics, Inc. Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
A detailed history of Quadrant Capital Group LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 16,031 shares of ADMA stock, worth $282,626. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,031
Previous 602
2562.96%
Holding current value
$282,626
Previous $10,000
3080.0%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ADMA
# of Institutions
378Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$329 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$297 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$227 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$202 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$99.9 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.46B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...